Cite
HARVARD Citation
Lala, M. et al. (2021). Corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020) 68–75]. European journal of cancer. pp. 400-. [Online].